Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Aditya Birla Capital among 6 midcap stocks flash bullish signals, indicating possible uptrend
On April 8, six NSE midcap stocks, including Aditya Birla Capital, formed White Marubozu bullish candlestick patterns, signaling strong buying pressure and a potential uptrend, highlighting trader optimism for continued price momentum.
Advent gets CCI nod to pick up 14.3% stake in Aditya Birla Housing Finance
The Competition Commission of India has approved Advent International's proposal to acquire a 14.3% stake in Aditya Birla Housing Finance. This move involves a significant capital infusion into the housing finance subsidiary. The CCI also cleared other acquisitions, including Citrus Investment LLC's increased shareholding in Hitachi Construction Machinery and Indus Infra Trust's acquisition of KNR SPVs.
Birla Estates garners sales of Rs 1,600 cr from Birla Arika Phase 2 project
Birla Estates, a wholly owned subsidiary of Aditya Birla Real Estate (ABREL), has achieved bookings exceeding Rs 1,600 crore for its luxury project, Birla Arika Phase 2 in Sector 31, Gurugram. Nearly 97% of the residences-152 of 156 units-were sold within a month of launch, underlining strong buyer confidence in the brand's luxury developments in Gurugram.
Retail industry reports high double-digit revenue growth in Q4, continues expansion
Retail companies like Trent, Avenue Supermarts, and V-Mart achieved robust double-digit revenue growth in the March quarter of FY26. This expansion was fueled by aggressive store additions and steady consumer demand. Companies reported significant year-on-year revenue increases, indicating a healthy retail environment.
Unimech Aerospace reports healthy order inflows in Q4
Unimech Aerospace and Manufacturing announced that its orderbook stood at approximately Rs 214 crore as of 31st March 2026, supported by better demand conditions and a healthy order book.
Auto scrips skid up to 27% in 3 months. Check Q4 expectations and 13 stocks to buy
Auto stocks have seen a significant drop of up to 27% in the last three months. This decline comes despite healthy vehicle demand. Investors are concerned about rising input costs, crude oil price volatility, and potential supply disruptions. Experts suggest continued underperformance in the near term. However, some analysts are identifying select stocks for potential investment opportunities.
Kalyan Jewellers shares jump 4% on strong Q4 numbers, Candere revenue spikes 360%
Kalyan Jewellers reported a strong March quarter performance with 64% revenue growth, driven by robust India demand and rising international sales. Candere saw exceptional traction, while store expansion continued. Despite geopolitical disruptions, momentum remains positive with strong wedding demand, festive outlook, and healthy advance collections supporting growth visibility ahead.
Sun Pharmaceutical Industries Ltd eases for fifth straight session
Sun Pharmaceutical Industries Ltd is quoting at Rs 1689.8, down 0.22% on the day as on 13:19 IST on the NSE. The stock jumped 1.41% in last one year as compared to a 3.17% rally in NIFTY and a 8.74% spurt in the Nifty Pharma index.
Sobha Ltd exits FY26 with record pre-sales. Is there room for growth?
Sobha sold around 5.5 million square feet of space in FY26, up 18.5% year-on-year; average realisation rose 9% year-on-year. Despite these positives and a healthy balance sheet, the mood is sombre
Sensex Today Trades Lower | Nifty Below 22,700 | Kotak Mahindra & Sun Pharma Top Losers - Equitymaster
Sensex Today Trades Lower | Nifty Below 22,700 | Kotak Mahindra & Sun Pharma Top LosersEquitymaster
Axis Bank shares in focus after lender's Q4 update beats estimates; advances grow 18%, deposits rise 14%
Axis Bank's Q4 business update revealed robust growth, with gross advances surging over 18% year-on-year and total deposits climbing nearly 14%. This performance surpassed brokerage expectations, showcasing strong momentum for the private lender. The bank's CASA and term deposits also saw significant year-on-year increases, indicating healthy customer engagement and financial expansion.
Nifty Pharma index drops 3% as US tariff fears hit Sun Pharma, peers
A Bloomberg report indicated that the Trump administration is planning tariffs on pharmaceutical companies that have not entered into agreements to ensure lower drug prices in the US.